Testimonials - YourXfactor

Orthopedic Surgery

Mattie

Physician assistant, Mattie Collier, explains how she incorporates a non‑opioid intervention applied in her office into her pain management approach to benefit patients undergoing knee surgery.

Play Video

Caroline

Caroline shares how the use of a non‑opioid cryoanalgesia treatment helped to provide immediate, long‑lasting pain relief before and after her total knee replacement procedures.

Play Video

Dr. Mighell

Dr. Mark Mighell, an orthopedic surgeon who specializes in the treatment of shoulder and elbow injuries, discusses his multimodal pain management approach, which includes the use of a long-acting local anesthetic injected during surgery.

Play Video

Stacey

Shoulder surgery patient, Stacey, explains how the use of a long-acting local anesthetic helped provide her with an enhanced recovery experience after surgery.

Play Video

Non-opioid options can be a true ‘X-Factor’ in helping provide women with the rapid rebound they’re looking for after surgery. Asking about these options should be at the top of any patient’s surgical planning checklist.

Dr Angela Stoehr | OB/GYN, Nurture Women’s Health in Frisco, TX

Education is power and an open dialogue is critical. It’s not only about better pain management and fewer side effects, but a smoother and quicker recovery process as well.

Dr Maggie Holtz | Chief of Regional & Orthopedic Anesthesia at WellStar Kennestone Regional Medical Center in Marietta, GA

Indication

The iovera° system is used to destroy tissue during surgical procedures by applying freezing cold. It can also be used to produce lesions in peripheral nervous tissue by the application of cold to the selected site for the blocking of pain. It is also indicated for the relief of pain and symptoms associated with osteoarthritis of the knee for up to 90 days. The iovera° system is not indicated for treatment of central nervous system tissue. The iovera° system’s “1×90” Smart Tip configuration (indicating one needle which is 90 mm long) can also facilitate target nerve location by conducting electrical nerve stimulation from a separate nerve stimulator.

IMPORTANT SAFETY INFORMATION

The iovera° system should not be used in people with the following conditions:

Blood that thickens when patient is exposed to cold (cryoglobulinemia), blood appearing in the urine when patient is exposed to the cold (paroxysmal cold hemoglobinuria), skin rash that appears when patient is exposed to the cold (cold urticaria), narrowing of the blood vessels in the hands and feet when patient is exposed to the cold (Raynaud’s disease), and open and/or infected wounds at or near the treatment sit

Patients being treated with the iovera° system (a needle-based therapy) may experience certain reactions, including, but not limited to:

Bruising, swelling, inflammation and/or redness, local pain and/or tenderness, and altered feeling at the site of application

Proper use of the device as described in the User Guide can help reduce or prevent the following reactions:

In the area(s) where you were treated: damage to the skin from being exposed to cold or heat, darkening or lightening of the skin, and dimples in the skin
Outside the area(s) where you were treated: muscles may not work or move normally

Indication

EXPAREL^® (bupivacaine liposome injectable suspension) is indicated in patients 6 years of age and older for single-dose infiltration to produce postsurgical local analgesia, and in adults as an interscalene brachial plexus nerve block to produce postsurgical regional analgesia. Safety and efficacy have not been established in other nerve blocks..

IMPORTANT SAFETY INFORMATION

EXPAREL should not be used in obstetrical paracervical block anesthesia.
In studies in adults where EXPAREL was injected into a wound, the most common side effects were nausea, constipation, and vomiting.
In studies in adults where EXPAREL was injected near a nerve, the most common side effects were nausea, fever, and constipation.
In the study where EXPAREL was given to children, the most common side effects were nausea, vomiting, constipation, low blood pressure, low number of red blood cells, muscle twitching, blurred vision, itching, and rapid heartbeat.
EXPAREL can cause a temporary loss of feeling and/or loss of muscle movement. How much and how long the loss of feeling and/or muscle movement depends on where and how much of EXPAREL was injected and may last for up to 5 days.
EXPAREL is not recommended to be used in patients younger than 6 years old for injection into the wound, for patients younger than 18 years old for injection near a nerve, and/or in pregnant women.
Tell your health care provider if you or your child has liver disease, since this may affect how the active ingredient (bupivacaine) in EXPAREL is eliminated from the body.
EXPAREL should not be injected into the spine, joints, or veins.
The active ingredient in EXPAREL can affect the nervous system and the cardiovascular system; may cause an allergic reaction; may cause damage if injected into the joints; and can cause a rare blood disorder.

You Are Now Leaving YourXFactor.com

Stay on YourXFactor.com continue to external site